Bayhill Therapeutics

Registration country: 
United States
ISIC Code: 
Company type: 
A biopharmaceutical company focused on the translation of research into therapeutics for the treatment of autoimmune diseases.
Bayhill Therapeutics is a clinical-stage biopharmaceutical company leveraging its proprietary therapeutic BHT-DNA™ platform to develop a pipeline of novel and targeted treatment candidates for autoimmune diseases. Through a targeted and selective approach, the Company’s product candidates are designed to restore the immune system to its normal state, known as “tolerance,” by eliminating specific, harmful immune responses while leaving the rest of the immune system intact.